Marie Dreger

Neurofilament light‐chain response during therapy with antisense oligonucleotide tofersen in <scp>SOD1</scp>‐related <scp>ALS</scp>: Treatment experience in clinical practice

Thomas Meyer, Peggy Schumann, Patrick Weydt et al. · Muscle & Nerve · 2023 · 97 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis—a cross‐sectional multicenter study

Thomas Meyer, Erma Salkic, Torsten Grehl et al. · European Journal of Neurology · 2023 · 45 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model

Marie Dreger, Robert Steinbach, Nayana Gaur et al. · Frontiers in Neuroscience · 2021 · 36 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study

Thomas Meyer, Marie Dreger, Torsten Grehl et al. · European Journal of Neurology · 2024 · 35 citations · Full text

Life Sciences, Neurology, Neuroscience +13

Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients

Jochen H. Weishaupt, Peter Körtvélyessy, Peggy Schumann et al. · Communications Medicine · 2024 · 27 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17